Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

How does market access impact the pharmaceutical commercialisation journey, and what role does it play in driving success ...

Here, we trace RWE's remarkable evolution from its handwritten roots through technological breakthroughs, methodological advancements, and regulatory milestones that have collectively elevated ...